Characterization of 89Zr-trastuzumab for clinical HER2 immunoPET imaging

被引：0
|
作者：
Dijkers, E.
Lub-de Hooge, M. N.
Kosterink, J. G.
Jager, P. L.
Brouwers, A. H.
Perk, L. R.
van Dongen, G. A.
de Vries, E. G.
机构：
[1] Univ Med Ctr Groningen, Groningen, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3508
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT
    Ulaner, Gary A.
    Hyman, David M.
    Ross, Dara S.
    Corben, Adriana
    Chandarlapaty, Sarat
    Goldfarb, Shari
    McArthur, Heather
    Erinjeri, Joseph P.
    Solomon, Stephen B.
    Kolb, Hartmuth
    Lyashchenko, Serge K.
    Lewis, Jason S.
    Carrasquillo, Jorge A.
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (10) : 1523 - 1528
  • [22] Potential and pitfalls of 89Zr-immuno-PET to assess target status: 89Zr-trastuzumab as an example
    Marc C. Huisman
    C. Willemien Menke-van der Houven van Oordt
    Josée M. Zijlstra
    Otto S. Hoekstra
    Ronald Boellaard
    Guus A. M. S. van Dongen
    Dhaval K. Shah
    Yvonne W. S. Jauw
    EJNMMI Research, 11
  • [23] Monitoring Afatinib Treatment in HER2-Positive Gastric Cancer with 18F-FDG and 89Zr-Trastuzumab PET
    Janjigian, Yelena Y.
    Viola-Villegas, Nerissa
    Holland, Jason P.
    Divilov, Vadim
    Carlin, Sean D.
    Gomes-DaGama, Erica M.
    Chiosis, Gabriela
    Carbonetti, Gregory
    de Stanchina, Elisa
    Lewis, Jason S.
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (06) : 936 - 943
  • [24] N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by 89Zr-Trastuzumab and 18F-FDG PET imaging
    Wimana, Zena
    Gebhart, Geraldine
    Guiot, Thomas
    Vanderlinden, Bruno
    Larsimont, Denis
    Doumont, Gilles
    Van Simaeys, Gaetan
    Goldman, Serge
    Flamen, Patrick
    Ghanem, Ghanem
    ONCOTARGET, 2017, 8 (34) : 56185 - 56198
  • [25] [64Cu]Cu-NOTA-Trastuzumab and [89Zr]Zr-DFO-Trastuzumab in Xenografts with Varied HER2 Expression
    Simo, Cristina
    Shmuel, Shayla
    Vanover, Alex
    Pereira, Patricia M. R.
    MOLECULAR PHARMACEUTICS, 2024, 21 (12) : 6311 - 6322
  • [26] Pharmacokinetics, Biodistribution, and Radiation Dosimetry for 89Zr-Trastuzumab in Patients with Esophagogastric Cancer
    O'Donoghue, Joseph A.
    Lewis, Jason S.
    Pandit-Taskar, Neeta
    Fleming, Stephen E.
    Schoder, Heiko
    Larson, Steven M.
    Beylergil, Volkan
    Ruan, Shutian
    Lyashchenko, Serge K.
    Zanzonico, Pat B.
    Weber, Wolfgang A.
    Carrasquillo, Jorge A.
    Janjigian, Yelena Y.
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (01) : 161 - 166
  • [27] Mucolytic Agents Can Enhance HER2 Receptor Accessibility for [89Zr]Trastuzumab, Improving HER2 Imaging in a Mucin-Overexpressing Breast Cancer Xenograft Mouse Model
    Zéna Wimana
    G. Gebhart
    T. Guiot
    B. Vanderlinden
    R. Morandini
    G. Doumont
    F. Sherer
    G. Van Simaeys
    S. Goldman
    G. Ghanem
    P. Flamen
    Molecular Imaging and Biology, 2015, 17 : 697 - 703
  • [28] Mucolytic Agents Can Enhance HER2 Receptor Accessibility for [89Zr]Trastuzumab, Improving HER2 Imaging in a Mucin-Overexpressing Breast Cancer Xenograft Mouse Model
    Wimana, Zena
    Gebhart, G.
    Guiot, T.
    Vanderlinden, B.
    Morandini, R.
    Doumont, G.
    Sherer, F.
    Van Simaeys, G.
    Goldman, S.
    Ghanem, G.
    Flamen, P.
    MOLECULAR IMAGING AND BIOLOGY, 2015, 17 (05) : 697 - 703
  • [29] A preclinical assessment of afatinib-treated HER2(+) gastric malignancies using Zr-89 trastuzumab
    Viola-Villegas, Nerissa
    Janjigian, Yelena
    Gomes-DaGama, Erica
    Holland, Jason
    de Stanchina, Elisa
    Lewis, Jason
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [30] 89Zr-Trastuzumab PET/CT Imaging of HER2-Positive Breast Cancer for Predicting Pathological Complete Response after Neoadjuvant Systemic Therapy: A Feasibility Study
    Linders, D. G. J.
    Deken, M. M.
    van Dam, M. A.
    Wasser, M. N. J. M.
    Voormolen, E. M. C.
    Kroep, J. R.
    van Dongen, G. A. M. S.
    Vugts, D.
    Oosterkamp, H. M.
    Straver, M. E.
    van de Velde, C. J. H.
    Cohen, D.
    Dibbets-Schneider, P.
    van Velden, F. H. P.
    Pereira Arias-Bouda, L. M.
    Vahrmeijer, A. L.
    Liefers, G. J.
    de Geus-Oei, L. F.
    Hilling, D. E.
    CANCERS, 2023, 15 (20)
12345